As of December 2024, Maxigen Biotech has a market cap of $127.56M. This makes Maxigen Biotech the world's 18535th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $127.83M | -2.89% |
2023 | $131.64M | 1.57% |
2022 | $129.60M | -8.19% |
2021 | $141.16M | 126.64% |
2020 | $62.28M | -9.31% |
2019 | $68.67M | 9.07% |
2018 | $62.96M | 2.43% |
2017 | $61.47M | -4.64% |
2016 | $64.46M | 1.72% |
2015 | $63.37M | -42.89% |
2014 | $110.97M | -23.16% |
2013 | $144.42M | 164.18% |
2012 | $54.67M | - |